Innovative Concepts in Drug Development Overview
- Year Founded
-
2007
- Status
-
Acquired/Merged
- Employees
-
5
- Latest Deal Type
-
M&A
Innovative Concepts in Drug Development General Information
Description
Provider of proprietary screening platforms designed to achieve targeted research to accelerate drug development and bring greater benefits to the patient. The company's platform helps to reduce product development costs by developing and making available the appropriate decision-making tools and product development technologies, enabling researchers to tackle some of the more difficult to treat diseases that are associated with high overall costs to society, such as neurodegenerative diseases.
Contact Information
Primary Industry
Biotechnology
Acquirer
GeneStore
Primary Office
- 800 Avenue du Château de Jouques
- 13420 Gemenos
- France
+33 04 00 00 00 00
Innovative Concepts in Drug Development Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Merger/Acquisition | 01-Jan-2019 | 00.000 | Completed | Generating Revenue | ||
| 4. Grant | 01-Jan-2014 | 00.000 | Completed | Generating Revenue | ||
| 3. Later Stage VC | 15-Jan-2013 | 00.000 | 00.000 | Completed | Generating Revenue | |
| 2. Accelerator/Incubator | 29-Nov-2012 | $1.64M | Completed | Generating Revenue | ||
| 1. Capitalization | 01-Jan-2009 | $1.64M | $1.64M | Completed | Generating Revenue |
Innovative Concepts in Drug Development Patents
Innovative Concepts in Drug Development Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-2924583-A1 | Method of screening for compounds useful in the treatment of alzheimer disease | Inactive | 20-Sep-2013 | 00000000000 | |
| EP-3047279-A1 | Method of screening for compounds useful in the treatment of alzheimer disease | Inactive | 20-Sep-2013 | 00000000000 | |
| JP-2016536611-A | Methods for screening for compounds useful for the treatment of alzheimer's disease | Pending | 20-Sep-2013 | 00000000000 | |
| US-20160223525-A1 | Method of screening for compounds useful in the treatment of alzheimer disease | Inactive | 20-Sep-2013 | 00000000000 | 0 |
| CA-2924579-A1 | Method of screening for compounds useful in the treatment of huntington disease | Pending | 20-Sep-2013 | G01N33/6896 |
Innovative Concepts in Drug Development Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Innovative Concepts in Drug Development Former Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| CDPS | Angel Group | Minority | 000 0000 | 000000 0 | |
| Grand Delta Angels | Angel Group | Minority | 000 0000 | 000000 0 | |
| Incubateur Impulse | Accelerator/Incubator | 000 0000 | 000000 0 | ||
| Michael J. Fox Foundation | Limited Partner | 000 0000 | 000000 0 | ||
| Région Sud Investissement | Venture Capital | Minority | 000 0000 | 000000 0 |